Showing results (491-500 of 722) with videos related to

Sort By:
Pageof 73
The Lancet. Haematology|January 26, 2023
The effect of granulocyte-colony stimulating factor, decitabine, and busulfan-cyclophosphamide versus busulfan-cyclophosphamide conditioning on relapse in patients with myelodysplastic syndrome or secondary acute myeloid leukaemia evolving from myelodysplastic syndrome undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised, phase 3 trialLi Xuan, Min Dai, Erlie Jiang, et al.
The Lancet. Haematology|February 1, 2023
Racial and ethnic disparities in childhood and young adult acute lymphocytic leukaemia: secondary analyses of eight Children's Oncology Group cohort trialsSumit Gupta, Yunfeng Dai, Zhiguo Chen, et al.
The Lancet. Haematology|March 1, 2023
Improving outcomes of childhood and young adult non-Hodgkin lymphoma: 25 years of research and collaboration within the framework of the European Intergroup for Childhood Non-Hodgkin LymphomaAuke Beishuizen, Karin Mellgren, Mara Andrés, et al.
The Lancet. Haematology|November 20, 2022
Brentuximab vedotin plus nivolumab after autologous haematopoietic stem-cell transplantation for adult patients with high-risk classic Hodgkin lymphoma: a multicentre, phase 2 trialAlex F Herrera, Lu Chen, Yago Nieto, et al.
The Lancet. Haematology|November 5, 2025
Patient-reported outcomes with belantamab mafodotin, pomalidomide, and dexamethasone versus bortezomib, pomalidomide, and dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-8): a phase 3, open-label, randomised controlled trialMeletios A Dimopoulos, Meral Beksac, Ludek Pour, et al.
The Lancet. Haematology|October 8, 2025
Incidence, mortality, and survival associated with acute leukaemia subtypes by age group in China: a population-based cancer registry analysis and cohort studyWei Yin, Xiaoyu Yan, Jiaoyang Cai, et al.
The Lancet. Haematology|September 5, 2021
Safe blood supply in sub-Saharan Africa: challenges and opportunitiesYvonne Dei-Adomakoh, Lucy Asamoah-Akuoko, Bernard Appiah, et al.
The Lancet. Haematology|September 20, 2025
Rituximab, bendamustine, and cytarabine followed by venetoclax in older patients with high-risk mantle cell lymphoma (FIL_V-RBAC): a multicentre, single-arm, phase 2 studyCarlo Visco, Valentina Tabanelli, Maria Vittoria Sacchi, et al.
The Lancet. Haematology|September 17, 2025
Emerging therapeutic strategies for mature T-cell and natural killer-cell lymphomasEric Tse, Christiane Querfeld, Kenji Ishitsuka, et al.
The Lancet. Haematology|August 10, 2025
Oral decitabine and cedazuridine maintenance after haematopoietic stem-cell transplantation in very high-risk acute myeloid leukaemia or myelodysplastic syndrome (GFM-DACORAL-DLI): a multicentre, single-arm, phase 2 trialMarie Robin, Maud D'Aveni, Aspasia Stamatoullas, et al.
Pageof 73